295 related articles for article (PubMed ID: 23708048)
21. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
[TBL] [Abstract][Full Text] [Related]
22. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
[TBL] [Abstract][Full Text] [Related]
23. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.
Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H
Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256
[TBL] [Abstract][Full Text] [Related]
24. miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator.
Yamashita D; Kondo T; Ohue S; Takahashi H; Ishikawa M; Matoba R; Suehiro S; Kohno S; Harada H; Tanaka J; Ohnishi T
Cancer Res; 2015 Mar; 75(6):1123-33. PubMed ID: 25627976
[TBL] [Abstract][Full Text] [Related]
25. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
[TBL] [Abstract][Full Text] [Related]
26. Tumor microvasculature supports proliferation and expansion of glioma-propagating cells.
Borovski T; Verhoeff JJ; ten Cate R; Cameron K; de Vries NA; van Tellingen O; Richel DJ; van Furth WR; Medema JP; Sprick MR
Int J Cancer; 2009 Sep; 125(5):1222-30. PubMed ID: 19431144
[TBL] [Abstract][Full Text] [Related]
27. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity.
Zhuang W; Li B; Long L; Chen L; Huang Q; Liang Z
Int J Cancer; 2011 Dec; 129(11):2720-31. PubMed ID: 21384342
[TBL] [Abstract][Full Text] [Related]
28. A novel technique to quantify glioma tumor invasion using serial microscopy sections.
Akella NS; Ding Q; Menegazzo I; Wang W; Gillespie GY; Grammer JR; Gladson CL; Nabors LB
J Neurosci Methods; 2006 Jun; 153(2):183-9. PubMed ID: 16406041
[TBL] [Abstract][Full Text] [Related]
29. A therapeutic cancer vaccine against GL261 murine glioma.
Kindy MS; Yu J; Zhu H; Smith MT; Gattoni-Celli S
J Transl Med; 2016 Jan; 14():1. PubMed ID: 26727970
[TBL] [Abstract][Full Text] [Related]
30. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
31. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
32. Isolation of Glioma-Initiating Cells for Biological Study.
Hu J; Markowitz G; Wang XF
Adv Exp Med Biol; 2016; 899():197-209. PubMed ID: 27325268
[TBL] [Abstract][Full Text] [Related]
33. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
34. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
[TBL] [Abstract][Full Text] [Related]
35. Pathological features of highly invasive glioma stem cells in a mouse xenograft model.
Sadahiro H; Yoshikawa K; Ideguchi M; Kajiwara K; Ishii A; Ikeda E; Owada Y; Yasumoto Y; Suzuki M
Brain Tumor Pathol; 2014 Apr; 31(2):77-84. PubMed ID: 23670138
[TBL] [Abstract][Full Text] [Related]
36. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
[TBL] [Abstract][Full Text] [Related]
37. Endothelium-induced three-dimensional invasion of heterogeneous glioma initiating cells in a microfluidic coculture platform.
Chonan Y; Taki S; Sampetrean O; Saya H; Sudo R
Integr Biol (Camb); 2017 Sep; 9(9):762-773. PubMed ID: 28752870
[TBL] [Abstract][Full Text] [Related]
38. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis.
Yang YP; Chang YL; Huang PI; Chiou GY; Tseng LM; Chiou SH; Chen MH; Chen MT; Shih YH; Chang CH; Hsu CC; Ma HI; Wang CT; Tsai LL; Yu CC; Chang CJ
J Cell Physiol; 2012 Mar; 227(3):976-93. PubMed ID: 21503893
[TBL] [Abstract][Full Text] [Related]
40. Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.
Barbieri F; Wurth R; Ratto A; Campanella C; Vito G; Thellung S; Daga A; Cilli M; Ferrari A; Florio T
Exp Cell Res; 2012 Apr; 318(7):847-60. PubMed ID: 22366263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
